For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Anti-Aging & Longevity · Comparison

Epithalon vs Thymalin

A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

EpithalonThymalin
CategoryAnti-Aging & LongevityAnti-Aging & Longevity
Also known asEpitalon, Epithalone, Tetrapeptide Ala-Glu-Asp-Glythymic peptide bioregulator, T-activin extract, thymus peptide, thymic bioregulator
EvidenceResearch-stageResearch-stage
Dosing range5mg–20mg mg, daily for 10–20 day cycles, 1–2x per year5mg–20mg mg, 5–10 day course, 1–2x per year
AdministrationSubcutaneous injection, Intravenous (clinical studies), IntranasalIntramuscular injection, Subcutaneous injection
Key side effectsGenerally very well-tolerated, Injection site discomfort, Vivid dreams (commonly reported), Improved sleep depth (often reported as benefit)Injection site reactions, Mild fever (rare), Temporary increase in immune activity (desired response), Rare hypersensitivity
Cited sources2 references2 references

Key differences

  • Administration: Epithalon — Subcutaneous injection, Intravenous (clinical studies), Intranasal; Thymalin — Intramuscular injection, Subcutaneous injection.
  • Frequency: Epithalon is typically daily for 10–20 day cycles, 1–2x per year; Thymalin is 5–10 day course, 1–2x per year.

How each works

Epithalon

Epithalon activates telomerase (hTERT), the enzyme responsible for maintaining telomere length. In vitro and animal studies show telomere elongation, extended cell lifespan, and reduced DNA oxidation. Russian clinical studies in aging populations report improved melatonin rhythms, immune function, and reduced cancer incidence over multi-year follow-up.

Thymalin

Thymalin contains multiple bioactive peptides that stimulate T-lymphocyte differentiation and restore thymic function that declines with age. In Khavinson's 6-year controlled trial of elderly patients (78–89 years), annual thymalin courses were associated with significantly lower mortality and improved immune parameters vs. controls. Proposed mechanisms include telomerase activation in immune cells and restoration of thymic epithelial cell function.

Read the full Epithalon profileRead the full Thymalin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.